These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10608299)

  • 1. Induction of negative regulators of haematopoiesis in human bone marrow cells by HLA-DR cross-linking.
    Yamaguchi M; Nadler S; Lee JW; Deeg HJ
    Transpl Immunol; 1999 Sep; 7(3):159-68. PubMed ID: 10608299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.
    Lee JW; Gersuk GM; Kiener PA; Beckham C; Ledbetter JA; Deeg HJ
    J Immunol; 1997 Oct; 159(7):3211-9. PubMed ID: 9317119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.
    Yamaguchi M; McSweeney PA; Kimball L; Gersuk G; Hong DS; Kwok W; Storb R; Beckham C; Deeg HJ
    Transplantation; 1999 Oct; 68(8):1161-71. PubMed ID: 10551646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR-mediated signals for hematopoiesis and induction of apoptosis involve but are not limited to a nitric oxide pathway.
    Lee JW; Beckham C; Michel BR; Rosen H; Deeg HJ
    Blood; 1997 Jul; 90(1):217-25. PubMed ID: 9207456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.
    Gersuk GM; Beckham C; Loken MR; Kiener P; Anderson JE; Farrand A; Troutt AB; Ledbetter JA; Deeg HJ
    Br J Haematol; 1998 Oct; 103(1):176-88. PubMed ID: 9792306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II and negative regulators of hematopoiesis.
    Deeg HJ; Lesnikov V
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):285-91. PubMed ID: 9832067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction.
    Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Yoshida N; Nakayama K
    J Immunol; 2002 Nov; 169(9):4732-8. PubMed ID: 12391181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
    Sato T; Selleri C; Anderson S; Young NS; Maciejewski JP
    Br J Haematol; 1997 May; 97(2):356-65. PubMed ID: 9163602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR inhibits granulocytic differentiation without inducing apoptosis of CD34 cells.
    Bertho N; Drénou B; Mooney N; Amiot L; Langanay T; Le Berre C; Charron D; Fauchet R
    Hum Immunol; 1999 Oct; 60(10):944-54. PubMed ID: 10566594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells.
    Bárcena A; Muench MO; Song KS; Ohkubo T; Harrison MR
    Exp Hematol; 1999 Sep; 27(9):1428-39. PubMed ID: 10480434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
    Lewis NR; Pallis M; Russell NH
    Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities.
    Léveillé C; Zekki H; Al-Daccak R; Mourad W
    Int Immunol; 1999 May; 11(5):719-30. PubMed ID: 10330277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in the immune system: 1. Fas-induced apoptosis in monocytes-derived human dendritic cells.
    Nat R; Radu E; Regalia T; Popescu LM
    J Cell Mol Med; 2002; 6(2):223-34. PubMed ID: 12169207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
    Altomonte M; Pucillo C; Damante G; Maio M
    J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.
    Tsushima H; Imaizumi Y; Imanishi D; Fuchigami K; Tomonaga M
    Exp Hematol; 1999 Mar; 27(3):433-40. PubMed ID: 10089905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZAP-70 and p72syk are signaling response elements through MHC class II molecules.
    Kanner SB; Grosmaire LS; Blake J; Schieven GL; Masewicz S; Odum N; Ledbetter JA
    Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):145-54. PubMed ID: 8525473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II molecule-mediated signal transduction mechanism responsible for the expression of interleukin-1 beta and tumor necrosis factor-alpha genes induced by a staphylococcal superantigen.
    Matsuyama S; Koide Y; Yoshida TO
    Eur J Immunol; 1993 Dec; 23(12):3194-202. PubMed ID: 8258334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.